title: The safety and tolerability of switching from a non-failing antiretroviral regimen to lopinavir.
authors.forename: Y
authors.initials: Y
authors.lastname: Gilleece
authors.forename: S
authors.initials: S
authors.lastname: Mandalia
authors.forename: D
authors.initials: D
authors.lastname: Parmar
authors.forename: M
authors.initials: M
authors.lastname: Nelson
mesh_terms: D000328:Adult; D018791:CD4 Lymphocyte Count; D002784:Cholesterol / Q000097:blood; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D019562:Viral Load
chemical_list: D011744:Pyrimidinones; D014280:Triglycerides; D061466:Lopinavir; D002784:Cholesterol